70 results
6-K
EX-99.1
ATHE
Alterity Therapeutics Ltd
28 Feb 24
Results for announcement to the market
5:46pm
of Ethics for Professional Accountants (including Independence Standards) (the Code) that are relevant to the audit of the annual financial report
6-K
EX-99.1
ATHE
Alterity Therapeutics Ltd
31 Aug 23
Report of Foreign Private Issuer
12:58pm
OF PROCEEDS
ITEM 15.
CONTROLS AND PROCEDURES
ITEM 16.
RESERVED
ITEM 16A.
AUDIT COMMITTEE FINANCIAL EXPERT
ITEM 16B.
CODE OF ETHICS
ITEM 16C.
PRINCIPAL … or regulatory delays, including delays in obtaining approvals from applicable hospital ethics committees and internal review boards;
slower than expected patient
6-K
EX-99.1
ATHE
Alterity Therapeutics Ltd
31 Aug 23
Report of Foreign Private Issuer
10:11am
Principle 8: Remunerate fairly and responsibly
Introduction
The Board and Management of the Company are committed to maintaining high standards of ethics
6-K
EX-99.1
ATHE
Alterity Therapeutics Ltd
13 Oct 22
Alterity Therapeutics Launches ATH434 Phase 2 Clinical Trial in Australia for the Treatment of Individuals with Multiple System Atrophy
6:07am
Ethics Committee (HREC) to conduct the Phase 2 clinical trial of ATH434 for the treatment of individuals with Multiple System Atrophy (MSA). Alterity … has also opened enrolment at its first clinical trial site in Sydney.
“We are thrilled to receive ethics approval and launch our first clinical trial
6-K
EX-99.1
vw62wqo m5
31 Aug 22
Report of Foreign Private Issuer
11:54am
6-K
EX-99.4
wabnls6k 3csydl
28 Feb 22
Results for announcement to the market
7:06am
6-K
EX-99.1
mzhm72ajpp5gr7ae66
3 Sep 21
Report of Foreign Private Issuer
6:15am
6-K
EX-99.1
mu1o00d8scf
25 Feb 21
Results for announcement to the market
6:16am
6-K
EX-99.1
be1qgb
9 Sep 20
Report of Foreign Private Issuer
6:55am
6-K
EX-99.1
5yw9zpiftxnx z3
30 Aug 19
Report of Foreign Private Issuer
3:49pm
6-K
0a3yayjwgvssg8v6o94u
6 Mar 19
Current report (foreign)
6:05am
6-K
1060lmskdf nid
27 Jun 18
Current report (foreign)
6:22am